SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-18-003028
Filing Date
2018-03-15
Accepted
2018-03-15 17:12:27
Documents
100
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f20f2017_xtlbiopharma.htm 20-F 1835305
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO RULE 13A-14(A)/15D-14(A), A f20f2017ex12-1_xtlbiopharma.htm EX-12.1 17213
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO RULE 13A-14(A)/15D-14(A), A f20f2017ex12-2_xtlbiopharma.htm EX-12.2 18116
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER PURSUANT TO f20f2017ex13-1_xtlbiopharma.htm EX-13.1 8606
5 CONSENT OF KESSELMAN & KESSELMAN, A MEMBER FIRM OF PRICEWATERHOUSECOOPERS INTERN f20f2017ex15-1_xtlbiopharma.htm EX-15.1 5367
12 GRAPHIC image_001.jpg GRAPHIC 70180
13 GRAPHIC image_002.jpg GRAPHIC 2314
  Complete submission text file 0001213900-18-003028.txt   6375424

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE xtlb-20171231.xml EX-101.INS 1113716
7 XBRL SCHEMA FILE xtlb-20171231.xsd EX-101.SCH 88252
8 XBRL CALCULATION FILE xtlb-20171231_cal.xml EX-101.CAL 45146
9 XBRL DEFINITION FILE xtlb-20171231_def.xml EX-101.DEF 143216
10 XBRL LABEL FILE xtlb-20171231_lab.xml EX-101.LAB 476258
11 XBRL PRESENTATION FILE xtlb-20171231_pre.xml EX-101.PRE 325840
Mailing Address 5 HACHAROSHET ST. RAANANA L3 4365603
Business Address XTL BIOPHARMACEUTICALS LTD C/O ALSTON & BIRD LLP, 90 PARK AVENUE NEW YORK NY 10016 972 9 955 7080
XTL BIOPHARMACEUTICALS LTD (Filer) CIK: 0001023549 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3
Type: 20-F | Act: 34 | File No.: 001-36000 | Film No.: 18693304
SIC: 2834 Pharmaceutical Preparations